Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …

Background The interleukin‐1 (IL‐1) mediated systemic autoinflammatory diseases, including
the cryopyrin‐ associated periodic syndromes (CAPS), tumour necrosis factor receptor‐…

Objective To describe probabilities and characteristics of disease flares in children with juvenile
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …

Objective To describe changes in health‐related quality of life ( HRQ oL) over time in children
with juvenile idiopathic arthritis ( JIA ), relative to other outcomes, and to identify predictors …

Background With modern treatments, the effect of juvenile idiopathic arthritis (JIA) on growth
may be less than previously reported. Our objective was to describe height, weight and …

Objective. We studied an inception cohort of children with juvenile idiopathic arthritis (JIA) to
(1) identify distinct disease courses based on changes over 5 years in 5 variables prioritized …

Background Joint inflammation is the common feature underlying juvenile idiopathic arthritis
(JIA). Clinicians recognize patterns of joint involvement currently not part of the International …

Background Paediatric inflammatory multisystem syndrome (PIMS) is a rare condition temporally
associated with SARS-CoV-2 infection. Using national surveillance data, we compare …

Objective. To assess which clinical features are most important for patients, parents, and
clinicians in the course of juvenile idiopathic arthritis (JIA). Methods. Forty-nine people …

Objective. To estimate the probability of early remission with conventional treatment for each
child with juvenile idiopathic arthritis (JIA). Children with a low chance of remission may be …